Allopurinol

  • TRADE NAMES: Allo 300; Allo-Puren; Alloprin; Atisuril; Bleminol; Caplenal; Duzallo (AstraZeneca); Hamarin; Novo-Purol; Purinol; Unizuric; Zyloprim (Prometheus); Zyloric
  • INDICATIONS: Gouty arthritis
  • CLASS: Purine analog, Xanthine oxidase inhibitor
  • HALF-LIFE: <3 hours

HLA-B*5801 confers a risk of allopurinol-induced serious skin reactions like SJS/TEN and DRESS.

Duzallo is allopurinol and lesinurad (see separate entry).

Our database has 110 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
NAILS
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
ENDOCRINE/METABOLIC
GENITOURINARY
RENAL
HEMATOLOGIC
OCULAR
OTHER


Page last updated 12/11/2017

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric